Special article
Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: Results of an IUIS/WHO collaborative study

https://doi.org/10.1016/0165-2478(85)90082-3Get rights and content

Abstract

Seventy-four monoclonal antibodies (McAb) of putative specificity for human IgG (11), the IgG subclasses (59) or Gm allotypes (4) have been evaluated for reactivity and specificity in eight laboratories employing different assay techniques or protocols. For the IgG, IgG3, IgG4, G1m(f) and G3m(u) specificities McAb have been produced that can be satisfactorily applied in most methodologies employed and have potential as reference reagents. The IgG1 and particularly IgG2 specificities proved problematical with all McAb evaluated demonstrating apparent assay restriction and whilst performing well in some assays proved to be poor or inactive reagents in others. However, the study identifies McAb individually suited to application within most commonly employed methodologies. Epitope display is the probable variability rather than capricious behaviour by the McAb. IgG1 and IgG2 were the least immunogenic of the sub-class proteins and there is evidence that epitope display is influenced by the physical and chemical procedures used to immobilize or fix antigen — a common requirement in the assay systems studied.

References (21)

  • R. Jefferis et al.

    Immunol. Today

    (1984)
  • J. Lowe et al.

    Immunology

    (1982)
  • D.J. Phillips et al.
  • R. Jefferis et al.

    Immunology

    (1982)
  • M. Van der Giessen et al.

    Immunology

    (1974)
  • J.B. Natvig et al.

    Adv. Immunol.

    (1972)
  • H. Spiegelberg

    Adv. Immunol.

    (1974)
  • F. Shakib et al.

    Ric. Clin. Lab.

    (1980)
    F. Shakib et al.

    Ric. Clin. Lab.

    (1980)
  • W.J. Yount et al.

    J. Exp. Med.

    (1968)
  • G. Kohler et al.

    Nature (London)

    (1975)
There are more references available in the full text version of this article.

Cited by (329)

  • Selection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells

    2019, Journal of Immunological Methods
    Citation Excerpt :

    In turn, IgG3 and IgA1 show elongated hinge domains that have an impact on the orientation of the V domains, and confer a higher susceptibility to proteases, compared to other Ig subclasses of the same isotype (Schroeder and Cavacini, 2010; Vidarsson et al., 2014). In line with this, most epitopes targeted by the Ab clones that showed strong reactivity on human B-cells and PCs in our study, had been previously mapped in the CH2 and the hinge domains (Hamilton and Morrison, 1993; Harada et al., 1991; Jefferis et al., 1992, 1985; Lighaam et al., 2014; Mestecky et al., 1996; Reimer et al., 1989, 1984). In contrast, all Ab clones targeting the CH3 Igγ-heavy chain region, such as the HP6011, HP6023, HP6025 and HP6206 Ab clones (Hamilton and Morrison, 1993; Jefferis et al., 1992, 1985; Lighaam et al., 2014) systematically failed to show a specific, reproducible and robust staining profile on human B-cells and PCs.

  • Peptide Antibodies in Clinical Laboratory Diagnostics

    2017, Advances in Clinical Chemistry
  • Clinical laboratory assessment of immediate-type hypersensitivity

    2010, Journal of Allergy and Clinical Immunology
    Citation Excerpt :

    Historically, IgG4 reaginic antibodies were believed to be diagnostic because monoclonal anti-human IgG4 could induce BHR from allergic donors cells.48 In 1992, this issue was challenged by Lichtenstein et al,49 who showed no histamine release (<10%) was detected from nonatopic donor cells after incubation with a panel of highly specific International Union of Immunological Societies–documented human IgG subclass–specific mAbs.50 Moreover, 85% of these same cells released to anti-IgE.

View all citing articles on Scopus

For full addresses see Appendices I and II.

View full text